U.S. bill could remove Chinese firms from U.S. exchanges
BEIJING – China said on Monday it firmly opposed U.S. President Trump signing a bill that would kick Chinese companies off U.S. stock exchanges unless they adhere to U.S. auditing standards, saying it contains discriminatory provisions against Chinese companies. “This … Continue reading U.S. bill could remove Chinese firms from U.S. exchanges
Covid-19: Baricitinib plus remdesivir shows promising
Washington – The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the … Continue reading Covid-19: Baricitinib plus remdesivir shows promising
U.S. adds four more Chinese firms to Pentagon blacklist
WASHINGTON – Washington is poised to designate four more Chinese companies as backed by the Chinese military, sources said, curbing their access to U.S. investors as the Trump administration seeks to cement its hawkish China legacy in its waning days. … Continue reading U.S. adds four more Chinese firms to Pentagon blacklist
China congratulates Biden on winning the presidency
BEIJING – China on Friday congratulated U.S. President-elect Joe Biden, who won the Nov. 3 election that President Donald Trump has not conceded, nearly a week after the former vice president clinched enough states for the win. “We respect the … Continue reading China congratulates Biden on winning the presidency
COVID Vaccine: Moderna is conducting a clinical trial
Washington – Moderna has finished accumulating data for a first analysis of its COVID-19 vaccine and expects to have an announcement on the vaccine’s efficacy by the end of the month, the company said in a statement Wednesday. Pfizer announced Monday that … Continue reading COVID Vaccine: Moderna is conducting a clinical trial
COVID-19: NIH begins large clinical trial
Washington – The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which … Continue reading COVID-19: NIH begins large clinical trial
NIH study identifies promising COVID-19 treatments
Washington – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 … Continue reading NIH study identifies promising COVID-19 treatments
Tesla to acquire German battery assembly maker
Palo Alto – Tesla Inc has agreed to acquire German ATW Automation, a supplier assembling battery modules and packs for the auto industry, a source familiar with the transaction said on Friday. ATW, a subsidiary of Canadian ATS Automation Tooling … Continue reading Tesla to acquire German battery assembly maker
Investigational COVID-19 vaccine well-tolerated
Washington – A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England Journal of … Continue reading Investigational COVID-19 vaccine well-tolerated
China approves U.S. wealth management company
BEIJING – China has approved a wealth management joint venture between U.S. asset manager BlackRock Inc, Singapore state investor Temasek Holdings (Pte) Ltd and China Construction Bank Corp (CCB), as China gradually opens up its financial sector to international firms. … Continue reading China approves U.S. wealth management company